GlassScriptPhysician profile
Brett Katzen
NPI 1740288109
$3,356.67
in general payments reported to CMS, 2019-2025
15 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $34.48 · 2021: $2,255 · 2022: $73.29 · 2023: $207 · 2024: $258 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,337.17 | 2021-2024 | Rocklatan, Lensx |
| Johnson & Johnson Surgical Vision, INC. | $322.57 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Rxsight INC | $142.20 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Aerie Pharmaceuticals, INC. | $96.41 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.32 | 2019 | |
| Glaukos Corporation | $88.20 | 2019 | |
| Sun Pharmaceutical Industries INC. | $79.61 | 2023-2024 | Cequa |
| Rayner Intraocular Lenses Limited | $35.69 | 2022 | |
| Carl Zeiss Meditec, INC. | $34.48 | 2020 | |
| Ocular Therapeutix, INC. | $32.71 | 2023 | Dextenza |
| Omeros Corporation | $26.30 | 2021 | |
| Kala Pharmaceuticals, INC. | $24.93 | 2019 | |
| Allergan, INC. | $18.19 | 2022 | |
| Bausch & Lomb Americas INC. | $17.92 | 2025 | Scoutpro Osmolarity System |
| Shire North American Group INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Katzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.